Archives

by in
Entry Author Date Location
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
East Coast Life Sciences Roundup: ASCO, Follica, Aveo, & More 06/07/13 Boston
Epizyme Soars 50 Percent in IPO Debut 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More 05/10/13 Boston
Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs 05/09/13 Boston
Concert Pharma To Get $300M+ Per Drug in Celgene Pact 05/06/13 Boston
East Coast Life Sciences Roundup: Aveo, Forma, Regeneron, RainDance, & More 05/03/13 Boston
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
East Coast Life Sciences Roundup: Thermo, Alkermes, Acorda, Epizyme 04/19/13 Boston
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
East Coast Life Sciences Roundup: Merck, Celgene, PTC, Cerulean 03/08/13 Boston
Cerulean Pharma Arrives at Turning Point With Cancer Drug 03/06/13 Boston
Presage Snags $13M from Celgene to Pick Winning Cancer Drug Combos 03/05/13 Seattle
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
Celgene Wins FDA Approval of Third Myeloma Drug 02/08/13 New York
Celgene Drug Keeps Pancreatic Patients Alive an Extra Two Months in Trial 01/23/13 New York
Brook Byers of Kleiner Perkins on Sticking With Healthcare 01/16/13 San Francisco
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
Celgene, Sanofi, Stryker Execs Charged With Insider Trading 11/19/12 New York
Celgene Puts $35M into VentiRx, Gets Option to Buy Cancer Drugmaker 10/03/12 Seattle
Page 4 of 7 « previous page · next page »